Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PerkinElmer strengthens screening portfolio business

This article was originally published in Clinica

Executive Summary

Health sciences firm PerkinElmer has expanded its presence in the genetic screening market with the acquisition of the newborn metabolic screening business of Pediatrix Medical Group. The deal sees PerkinElmer gain Sunrise, Florida-based Pediatrix's StepOne newborn screening product. StepOne can analyse up to 50 inherited disorders in newborn children, claims PerkinElmer, and has been used to screen more than three million babies since Pediatrix's inception in 1994. PerkinElmer will also acquire Pediatrix's metabolic screen laboratory, which provides neonatal screening and consultancy to hospitals and medical groups, as well as the whole of Maryland, Mississippi, Louisiana, Nebraska, Pennsylvania and the District of Columbia.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050519

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel